Market Report | UNDERSTANDING THE FUTURE OF THE PHARMA CONTRACT MANUFACTURING INDUSTRY 2026

When you’re managing external manufacturing today, the pressure isn’t abstract; it’s daily, immediate, and growing. Capacity is tightening across sterile and biologics, global regulations are shifting faster than contracts can keep up, and geopolitical instability is reshaping where medicines can be made, sourced, and shipped.

This is exactly why the 2026 Pharma Contract Manufacturing Market Report was built: to give you the clarity, the benchmarks, and the competitive intelligence you need to make confident decisions in a market that isn’t standing still.

With expert commentary from Christian Simon, Head of Technical Transfer, External Manufacturing, Sanofi, and Philip Coetzee, Director, CMO Management, Daiichi Sankyo, they both share their insights on how to deliver reliability with less buffer, innovation with fewer resources, and agility with partners facing the same constraints you are.

Download to learn more about:

• Market Shifts You Need to Know: The global CMO/CDMO market is accelerating toward $319.6B by 2029, with biotech outsourcing growing more than 12% year-on-year.
• Risks You’re Navigating Every Day: Supply chain disruptions have increased by 38% in the past 12 months, driven by tariffs, sanctions, and regional realignments.
• What Makes Partnerships Actually Work in 2026: Strong alliances are built on shared visibility, structured communication, and joint planning, not just SLAs. Pharma teams that implement integrated review cycles with CMOs report 20-30% fewer delays and higher tech-transfer success.
• Innovation You Can’t Afford to Ignore: Digital twins and AI-based planning are improving cycle time by 15-40% in organisations already adopting them. Single-use systems continue to gain ground, reducing cleaning-related downtime by up to 60%.

If you’re operating in an environment where a single disruption – a delayed material, a missed forecast, an unexpected deviation – can ripple across your entire supply network. This report gives you the insights to anticipate those pressures, benchmark your partnerships, and build agility into your operations before the next disruption hits. Equip yourself with the intelligence to strengthen your CMO/CDMO relationships, negotiate with confidence, and protect your supply chain in the year ahead.

Download your copy now and stay ahead of the pressures reshaping pharma contract manufacturing.